Last quarter (Q ), MediXall Group's total revenue was $20.24K, a decrease of -112.76% from the same quarter last year. In Q, MediXall Group's net income was $-1.87M. See MediXall Group’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 59.27K	$ 59.27K	$ 180.71K	$ 0.00	$ 2.69K	$ 1.86K
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ 41.01K	$ 59.27K	$ 180.71K	-	-	-
Operating Expense	$ 10.02M	$ 6.89M	$ 6.38M	$ 5.93M	$ 3.42M	$ 2.90M
Operating Income	$ -4.16M	$ -4.16M	$ -3.53M	$ -5.93M	$ -3.42M	$ -2.90M
Net Non Operating Interest Income Expense	$ -271.12K	$ -271.12K	-	-	-	-
Other Income Expense	-	-	-	-	-	$ -86.67K
Pretax Income	$ -6.83M	$ -6.83M	$ -6.20M	$ -5.93M	$ -3.42M	$ -2.98M
Tax Provision	-	-	-	$ 0.00	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -7.14M	$ -7.14M	$ -6.45M	$ -5.97M	$ -3.42M	$ -2.98M
Basic EPS	$ -0.08	$ -0.06	$ -0.06	$ -0.07	$ -0.05	$ -0.05
Diluted EPS	$ -0.08	$ -0.06	$ -0.06	$ -0.07	$ -0.05	$ -0.05
Basic Average Shares	$ 464.33M	$ 116.66M	$ 104.20M	$ 90.63M	$ 74.13M	$ 65.01M
Diluted Average Shares	$ 464.33M	$ 116.66M	$ 104.20M	$ 90.63M	$ 74.13M	$ 65.01M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 10.02M	$ 6.89M	$ 6.38M	$ 5.93M	$ 3.42M	$ 2.90M
Net Income From Continuing And Discontinued Operation	$ -6.83M	$ -6.83M	$ -6.20M	$ -5.93M	$ -3.42M	$ -2.98M
Normalized Income	$ -3.96M	-	-	$ -5.93M	$ -3.42M	$ -2.90M
Interest Expense	-	-	-	-	-	-
EBIT	$ -6.56M	$ -6.56M	$ -6.20M	$ -5.93M	$ -3.42M	$ -2.90M
EBITDA	$ -6.38M	$ -6.32M	$ -6.12M	$ -5.93M	$ -3.42M	$ -2.89M

Currency in USD

MediXall Group Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing